Lincoln Pharmaceuticals Limited (BOM:531633)
India · Delayed Price · Currency is INR 613.45
+82.40 (15.52%)
At close: Feb 12, 2026
Lincoln Pharmaceuticals Market Cap
Lincoln Pharmaceuticals has a market cap or net worth of 12.97 billion as of February 13, 2026. Its market cap has decreased by -9.55% in one year.
Market Cap
12.97B
Enterprise Value
10.65B
Revenue
6.60B
Ranking
n/a
PE Ratio
14.77
Stock Price
613.45
Market Cap Chart
Since October 21, 2004, Lincoln Pharmaceuticals's market cap has increased from 138.90M to 12.97B, an increase of 9,238.23%. That is a compound annual growth rate of 23.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 12.29B | 26.96% |
| Dec 31, 2025 | 9.68B | -38.62% |
| Dec 31, 2024 | 15.77B | 29.24% |
| Dec 29, 2023 | 12.20B | 71.47% |
| Dec 30, 2022 | 7.12B | -0.74% |
| Dec 31, 2021 | 7.17B | 47.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Syncom Formulations (India) | 13.48B |
| TTK Healthcare | 13.42B |
| Kwality Pharmaceuticals | 11.80B |
| Venus Remedies | 10.01B |
| Fermenta Biotech | 9.64B |
| Wanbury | 8.97B |
| Fredun Pharmaceuticals | 8.42B |
| Anuh Pharma | 8.38B |